Irish patients not getting access to new medicines quickly enough says IPHA

The pharmaceutical industry claims that Irish patients are not getting access to new medicines quickly enough.

The Irish Pharmaceutical Healthcare Association says Ireland has the worst record in Europe when it comes to adopting new drugs.

The IPHA is discussing the issue at its annual conference today in Dublin.

Phillip Hannon from the IPHA says the method for deciding which drugs will be funded through by the HSE is too slow.

He said: "It is the processes that we have in terms of the reimbursement periods, the processs are wrong and I think need to be looked at.

"The minister himself said on the record in the Dail that the reimbursement system is broken."


Related Articles

Cases of Legionnaires’ disease more than double in 2017

Young adults drive diabetes research forward

Eating carbohydrates in moderation leads to long life, study finds

Calls for Govt to clarify if new Maternity Hospital will be run under Catholic ethos

More in this Section

Man arrested after cocaine seizure in Dublin

Taoiseach disappointed by Peter Fitzpatrick's decision not to contest next election

Status Yellow weather advisory warns of spot flooding

Irish Government hails Kofi Annan as 'voice for international peace'


More From The Irish Examiner